CFP-10

CFP-10

CFP-10 protein structure

CFP-10, also known as Culture Filtrate Protein 10, is a protein secreted by the bacterium Mycobacterium tuberculosis, the causative agent of tuberculosis. It is a key component of the ESAT-6 system, which is involved in the virulence of the bacterium. CFP-10, along with ESAT-6, forms a complex that is crucial for the pathogen's ability to evade the host's immune system.

Structure and Function

CFP-10 is a small protein with a molecular weight of approximately 10 kDa. It is encoded by the RD1 region of the Mycobacterium tuberculosis genome, which is absent in the BCG vaccine strain. The protein is characterized by its ability to form a tight complex with ESAT-6, another virulence factor. This complex is involved in the disruption of host cell membranes, facilitating the spread of the bacterium within the host.

Role in Pathogenesis

The CFP-10/ESAT-6 complex plays a significant role in the pathogenesis of tuberculosis. It is involved in the modulation of the host's immune response, allowing Mycobacterium tuberculosis to persist within macrophages. The complex interferes with the host's antigen presentation pathways, thereby inhibiting the activation of T cells and promoting bacterial survival.

Diagnostic and Vaccine Implications

CFP-10 protein in tuberculosis research

CFP-10 is a target for diagnostic tests for tuberculosis. The protein is used in interferon-gamma release assays (IGRAs), which are blood tests that measure the immune response to specific Mycobacterium tuberculosis antigens, including CFP-10. These tests are used to detect latent tuberculosis infections.

In terms of vaccine development, the absence of the RD1 region, which encodes CFP-10, in the BCG vaccine strain is a point of interest. Understanding the role of CFP-10 in virulence could lead to the development of more effective vaccines against tuberculosis.

Research and Future Directions

Research on CFP-10 continues to explore its role in the immune evasion strategies of Mycobacterium tuberculosis. Studies are focused on understanding the molecular interactions between CFP-10, ESAT-6, and host cell components. This knowledge could lead to novel therapeutic approaches targeting the CFP-10/ESAT-6 complex to enhance the host's immune response against tuberculosis.

Related pages

• Mycobacterium tuberculosis
• ESAT-6
• Tuberculosis
• BCG vaccine
• Interferon-gamma release assays